A new $4.8 million grant will support researchers from Indiana University School of Medicine and the Medical Research Council Laboratory of Molecular Biology to study how human neurodegenerative diseases are affected by the misfolding of the protein TDP-43.
Indiana University School of Medicine researchers recently were awarded $4.7 million from the Patient-Centered Outcomes Research Institute (PCORI) to further the study of caregiver intervention in reducing adolescent alcohol use and other substance use disorders (SUDs).
A new study recently published in Nature Structural and Molecular Biology uses leading-edge cryo-electron microscopy imaging technology to determine whether differences exist between the protein structures in those with Alzheimer’s disease and those with both Alzheimer’s disease and Down syndrome.
Black patients in need of a heart transplant may be less likely to receive one than white patients, according to a new study led by Indiana University School of Medicine researchers.
Reuben Kapur, director of the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine, is working to discover new treatments that will improve patient care.
Team of researchers led by Indiana University School of Medicine faculty have developed a breakthrough new blood test for schizophrenia, a psychiatric disorder that includes hallucinations and delusions.
Since its introduction to the public in November 2022, ChatGPT, an artificial intelligence system, has substantially grown in use, creating written stories, graphics, art and more with just a short prompt from the user.
An Indiana University School of Medicine surgeon-scientist is leading a multi-institutional grant investigating the role of the sinus microbiome in chronic rhinosinusitis, an inflammatory disease that causes the lining of the sinuses to swell.
IU School of Medicine investigators and their collaborators in Uganda has revealed that hydroxyurea significantly reduces infections in children with sickle cell anemia, which enhances strong evidence of hydroxyurea’s effectiveness and could ultimately reduce death in children in Africa.
An Indiana University biologist has been awarded $2.8 million from the National Institutes of Health to advance research on DNA folding errors, which have been traced to a wide variety of diseases, including genetic disorders that can cause birth defects or problems with wound healing, as well as certain types of cancer.
A beta blocker typically used to treat heart problems, hemangioma, migraines and anxiety could be a new therapeutic for patients with sickle cell disease.
Since Barbie's creation in the 1950s, she's gone through some drastic makeovers.
Indiana University researchers are collaborating on a novel approach to use neuroimaging and network modeling tools previously developed to analyze brains of patients in the clinic to investigate Alzheimer's disease progression in preclinical animal models.
A pioneering Alzheimer’s disease study led by Indiana University School of Medicine researchers is the focus of a special issue of Alzheimer’s & Dementia, the journal of the Alzheimer’s Association.
IU School of Medicine researchers are taking steps to improve the accessibility and quality of care for adolescents experiencing opioid use disorder (OUD) and other substance use disorders (SUDs), thanks to a new $5 million grant from the National Institute of Health's Helping to End Addiction Long-Term (HEAL) Initiative.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
